Papers
arxiv:2404.12141

MolCRAFT: Structure-Based Drug Design in Continuous Parameter Space

Published on Apr 18, 2024
Authors:
,
,
,
,
,
,
,

Abstract

MolCRAFT is the first SBDD model operating in continuous parameter space, addressing ill-conformational issues and achieving state-of-the-art binding affinity and 3D structure stability.

AI-generated summary

Generative models for structure-based drug design (SBDD) have shown promising results in recent years. Existing works mainly focus on how to generate molecules with higher binding affinity, ignoring the feasibility prerequisites for generated 3D poses and resulting in false positives. We conduct thorough studies on key factors of ill-conformational problems when applying autoregressive methods and diffusion to SBDD, including mode collapse and hybrid continuous-discrete space. In this paper, we introduce MolCRAFT, the first SBDD model that operates in the continuous parameter space, together with a novel noise reduced sampling strategy. Empirical results show that our model consistently achieves superior performance in binding affinity with more stable 3D structure, demonstrating our ability to accurately model interatomic interactions. To our best knowledge, MolCRAFT is the first to achieve reference-level Vina Scores (-6.59 kcal/mol) with comparable molecular size, outperforming other strong baselines by a wide margin (-0.84 kcal/mol). Code is available at https://github.com/AlgoMole/MolCRAFT.

Community

Sign up or log in to comment

Models citing this paper 3

Datasets citing this paper 0

No dataset linking this paper

Cite arxiv.org/abs/2404.12141 in a dataset README.md to link it from this page.

Spaces citing this paper 0

No Space linking this paper

Cite arxiv.org/abs/2404.12141 in a Space README.md to link it from this page.

Collections including this paper 0

No Collection including this paper

Add this paper to a collection to link it from this page.